222 related articles for article (PubMed ID: 33531895)
21. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis].
Eichel M; Just-Nübling G; Helm EB; Stille W
Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280
[TBL] [Abstract][Full Text] [Related]
22. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
23. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Fan SR; Liu XP
Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
[TBL] [Abstract][Full Text] [Related]
24. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.
López-Dupla M; Mora Sanz P; Pintado García V; Valencia Ortega E; Uriol PL; Khamashta MA; Aguado AG
Am J Gastroenterol; 1992 Dec; 87(12):1771-6. PubMed ID: 1449139
[TBL] [Abstract][Full Text] [Related]
25. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
26. Fungal Esophagitis in a Child with Insulin Dependent Diabetes Mellitus.
Saeed A; Assiri A; Zaidi Z; Alsheikh A
J Coll Physicians Surg Pak; 2016 Aug; 26(8):712-3. PubMed ID: 27539771
[TBL] [Abstract][Full Text] [Related]
27. Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.
Kalaiarasan K; Singh R; Chaturvedula L
J Clin Diagn Res; 2017 Mar; 11(3):DC06-DC09. PubMed ID: 28511380
[TBL] [Abstract][Full Text] [Related]
28. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of the pathogenic characteristics of fungal bloodstream infection in severe burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Shi YL; Liu TF; Li HY; Peng YZ
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):37-41. PubMed ID: 32023716
[No Abstract] [Full Text] [Related]
31. Epidemiological investigation of non-albicans Candida species recovered from mycotic mastitis of cows in Yinchuan, Ningxia of China.
Du J; Wang X; Luo H; Wang Y; Liu X; Zhou X
BMC Vet Res; 2018 Aug; 14(1):251. PubMed ID: 30157847
[TBL] [Abstract][Full Text] [Related]
32. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
33. Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.
Liu Y; Kang M; Ye H; Zong Z; Lv X
J Mycol Med; 2018 Mar; 28(1):222-226. PubMed ID: 29254811
[TBL] [Abstract][Full Text] [Related]
34. Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?
Wilson A; Delport J; Ponich T
Int J Microbiol; 2014; 2014():371631. PubMed ID: 25544843
[TBL] [Abstract][Full Text] [Related]
35. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
36. Candida esophagitis.
Mathieson R; Dutta SK
Dig Dis Sci; 1983 Apr; 28(4):365-70. PubMed ID: 6339183
[TBL] [Abstract][Full Text] [Related]
37. Current status and fluconazole treatment of pelvic fungal gynecological infections.
Mikamo H; Sato Y; Hayasaki Y; Tamaya T
Chemotherapy; 2000; 46(3):209-12. PubMed ID: 10765038
[TBL] [Abstract][Full Text] [Related]
38. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis.
Yassin MT; Mostafa AA; Al-Askar AA; Bdeer R
Eur J Med Res; 2020 Jan; 25(1):1. PubMed ID: 31901238
[TBL] [Abstract][Full Text] [Related]
39. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
[TBL] [Abstract][Full Text] [Related]
40. Candida esophagitis: species distribution and risk factors for infection.
Kliemann DA; Pasqualotto AC; Falavigna M; Giaretta T; Severo LC
Rev Inst Med Trop Sao Paulo; 2008; 50(5):261-3. PubMed ID: 18949340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
